Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-109077
Filing Date
2025-08-14
Accepted
2025-08-14 17:21:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8243
  Complete submission text file 0000950170-25-109077.txt   10206
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Subject) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91508 | Film No.: 251221109
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)